Cargando…

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial

Detalles Bibliográficos
Autores principales:	Gyselinck, Iwein, Liesenborghs, Laurens, Landeloos, Ewout, Belmans, Ann, Verbeke, Geert, Verhamme, Peter, Vos, Robin, Janssens, W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933907/ https://www.ncbi.nlm.nih.gov/pubmed/33673831 http://dx.doi.org/10.1186/s13063-021-05153-4

Ejemplares similares

Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2—azithromycin trial
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)
por: Gyselinck, Iwein, et al.
Publicado: (2022)

Rationale for azithromycin in COVID-19: an overview of existing evidence
por: Gyselinck, Iwein, et al.
Publicado: (2021)

Antiviral effects of azithromycin: A narrative review
por: Khoshnood, Saeed, et al.
Publicado: (2022)

Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial
por: Vermeersch, Kristina, et al.
Publicado: (2019)

Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID‐19
por: Damle, Bharat, et al.
Publicado: (2020)

Azithromycin: Immunomodulatory and antiviral properties for SARS-CoV-2 infection
por: Khezri, Mohammad Rafi, et al.
Publicado: (2021)

Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial
por: Liesenborghs, Laurens, et al.
Publicado: (2021)

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
por: Devos, Timothy, et al.
Publicado: (2022)

Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens”
por: Liesenborghs, Laurens, et al.
Publicado: (2021)

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
por: Devos, Timothy, et al.
Publicado: (2020)

Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
por: Devos, Timothy, et al.
Publicado: (2020)

Azithromycin effectiveness against intracellular infections of Francisella
por: Ahmad, Saira, et al.
Publicado: (2010)

Triangular test applied to the clinical trial of azithromycin against relapses in Plasmodium vivax infections
por: Ranque, Stéphane, et al.
Publicado: (2002)

Remdesivir, on the road to DisCoVeRy
por: Gyselinck, Iwein, et al.
Publicado: (2022)

Modulation of thromboinflammation in hospitalized COVID‐19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn‐Antico study
por: Engelen, Matthias M., et al.
Publicado: (2022)

Randomised controlled trial of azithromycin in smokers with asthma
por: Cameron, Euan J., et al.
Publicado: (2013)

Azithromycin, RECOVERY, and the power of large, simple trials
por: Berwanger, Otavio
Publicado: (2021)

Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal
por: Fantini, Jacques, et al.
Publicado: (2020)

Azithromycin (Zithromax(®))
por: McCarty, James M.
Publicado: (1996)

Azithromycin for Malaria?
por: Rosenthal, Philip J.
Publicado: (2016)

Liposomal Encapsulation Increases the Efficacy of Azithromycin against Chlamydia trachomatis
por: Bogdanov, Anita, et al.
Publicado: (2021)

Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants
por: Viscardi, Rose Marie, et al.
Publicado: (2020)

Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial
por: Oron, Assaf P., et al.
Publicado: (2020)

Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania
por: Bloch, Evan M., et al.
Publicado: (2020)

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
por: Molina, J.M., et al.
Publicado: (2020)

Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics
por: Baker, Kristin R., et al.
Publicado: (2019)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Azithromycin in viral infections
por: Oliver, Madeleine E., et al.
Publicado: (2020)

Azithromycin in acute bronchiolitis
por: Solé, Dirceu, et al.
Publicado: (2020)

Azithromycin-Induced Bradycardia
por: Abdelazeem, Basel, et al.
Publicado: (2021)

Rhabdomyolysis triggered by azithromycin
por: Finsterer, Josef, et al.
Publicado: (2022)

Fabrication of an Azithromycin Sensor
por: Niyitanga, Theophile, et al.
Publicado: (2023)

Randomized Trial of Erythromycin and Azithromycin for Treatment of Chlamydial Infection in Pregnancy
por: Rosenn, Marc F., et al.
Publicado: (1995)

Azithromycin for sarcoidosis cough: an open-label exploratory clinical trial
por: Fraser, Simon D., et al.
Publicado: (2020)

Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
por: Gibson, Peter G., et al.
Publicado: (2019)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study
por: Vanassche, T., et al.
Publicado: (2020)

Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials
por: Verstraete, Kenneth, et al.
Publicado: (2023)

A double-masked placebo-controlled trial of azithromycin to prevent child mortality in Burkina Faso, West Africa: Community Health with Azithromycin Trial (CHAT) study protocol
por: Sié, Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tuggns0pq0vi2gc010dckah7ab